Saturated long-chain fatty acid-modified 7-ethyl-10-hydroxycamptothecin compound and long-circulating liposome thereof

A long-circulating liposome and long-chain fatty acid technology, applied in the field of medicine, can solve the problems of easy oxidation of unsaturated fatty acids, no in-depth research, no explanation, etc., to achieve stable properties, improve tumor distribution, and facilitate storage Effect

Inactive Publication Date: 2016-07-20
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF11 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, unsaturated fatty acids are also used to modify SN-38 by esterification, such as BoB.Lundberg et al. using oleic acid for modification (LundbergBB.Biologicallyactivecamptothecinderivativesforincorporationintoliposomebilayersandlipidemulsions[J].Anti-cancerdrugdesign,1998,13(5):453-461); China Patent CN03818985.2 discloses a preparation method using a conjugate of camptothecin derivatives and long-chain unsaturated fatty acids. The publication number is CN1675219A. Although the patent mentions modifying SN-38 with long-chain unsaturated fatty acids, In this method, an intermediate "adapter chain" is used to link SN-38 with long-chain unsaturated fatty acids. Due to the existence of the "adapter chain", the compound synthesized by it is relatively irinotecan Whether it can be more effectively converted into SN-38 is not reflected in the patent, and due to the existence of the intermediate "connecting chain", the compound it synthesizes will definitely produce long-chain unsaturated fatty acids and SN-38 in the process of human metabolism. Other substances other than these "other" subst

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Saturated long-chain fatty acid-modified 7-ethyl-10-hydroxycamptothecin compound and long-circulating liposome thereof
  • Saturated long-chain fatty acid-modified 7-ethyl-10-hydroxycamptothecin compound and long-circulating liposome thereof
  • Saturated long-chain fatty acid-modified 7-ethyl-10-hydroxycamptothecin compound and long-circulating liposome thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0061] Embodiment 1: Preparation of 7-ethyl-10-hydroxycamptothecin-10-palmitate

[0062]Add 1mmol of 7-ethyl-10-hydroxycamptothecin to the reaction vessel, add 0.2L of anhydrous chloroform to dissolve, then add 1.2mmol of DIPEA, stir for 5 minutes under ice bath conditions, slowly drop 1.2mmol Palmitoyl chloride, continue to react for 15 minutes under ice-bath conditions, and then react for 4 hours at room temperature. The reactant is recrystallized in acetone, and 620.12 mg of 7-ethyl-10-hydroxycamptothecin-10-palmitate is isolated , yield 98.37%.

[0063] The HNMR and MS (ESI) data of this material are as follows:

[0064] 1H NMR (CDCl3, 600MHz) δ: 8.22 (1H, d, J = 9.12Hz), 7.81 (1H, d, J = 2.46Hz), 7.64 (1H, s), 7.54 (1H, dd, J = 9.12and J = 2.46Hz), 5.74(1H, d), 5.30(1H, d), 5.25(2H, s), 3.86(1H, s), 3.15(2H, q), 2.65(2H, t), 1.95-1.85( 2H, m), 1.84-1.79 (2H, m), 1.50-1.26 (27H, m), 1.03 (3H, t), 0.87 (3H, t).

[0065] MS (ESI - )m / z:629(M-H + ).

[0066] The chemic...

Embodiment 2

[0068] Embodiment 2: Preparation of 7-ethyl-10-hydroxycamptothecin-10-palmitate

[0069] Add 1 mmol of 7-ethyl-10-hydroxycamptothecin to the reaction vessel, add 1 L of anhydrous dichloromethane to dissolve, then add 2 mmol of triethylamine, stir for 30 minutes under ice bath conditions, slowly add 2 mmol of Palmitoyl chloride, continue to react for 45 minutes under ice bath conditions, and then react for 24 hours at room temperature. The reactant is recrystallized in ethyl acetate, and 7-ethyl-10-hydroxycamptothecin-10-palmitate is isolated 621.33 mg, yield 98.56%.

Embodiment 3

[0070] Example 3: Preparation of 7-ethyl-10-hydroxycamptothecin-10-palmitate

[0071] Add 1mmol of 7-ethyl-10-hydroxycamptothecin to the reaction vessel, add 0.5L of anhydrous N,N-dimethylformamide to dissolve, then add 1.5mmol of DMAP, and stir for 15 minutes under ice bath conditions , slowly add 1.5 mmol of palmitoyl chloride dropwise, continue to react for 20 minutes under ice-bath conditions, and then react for 8 hours at room temperature. The reactant is recrystallized in cyclohexane, and 7-ethyl-10-hydroxy camptotheca Base-10-palmitate 610.28 mg, yield 96.81%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of medicine, and relates to a saturated long-chain fatty acid-modified 7-ethyl-10-hydroxycamptothecin (SN-38) compound and a long-circulating liposome thereof. Under substitution reaction conditions and the existence of an acid-binding agent, SN-38 is subjected to saturated long-chain fatty acid chloride, such that a SN-38 monounsaturated fatty acid ester compound is obtained. The compound has a following general formula (I). The long-circulating liposome prepared with the compound provided by the invention has the advantages of improving drug anti-tumor effect, enhancing drug stability, reducing drug toxic and side effects, and the like.

Description

technical field [0001] The invention relates to the field of medical technology, in particular to a saturated long-chain fatty acid modified 7-ethyl-10-hydroxycamptothecin compound and its long-circulating liposome, its preparation method, and its application in antitumor drugs . Background technique [0002] Irinotecan hydrochloride (CPT-11) is a semi-synthetic soluble camptothecin derivative. The dosage forms currently on the market mainly include injection and freeze-dried powder injection. It mainly acts on the S phase of the cell cycle. Isomerase Ⅰ, which interferes with DNA replication and cell division, is used as a first-line drug in combination with fluorouracil and leucovorin in the treatment of patients with metabolic colon or rectal cancer, and can also be used to treat patients who have failed or relapsed after fluorouracil treatment Patients with metabolic colon or rectal cancer. This product can be used alone or in combination with other drugs for the treatm...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D491/22A61K31/4745A61K9/127A61P35/00
Inventor 陈建明吴婵张元声余侬高保安姚建忠刘文丽陈丽娜邓莉马娟娟
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap